A study from the Indian Council of Medical Research has claimed that Bharat Biotech's Covaxin is effective against the UK variant of the coronavirus.
Meanwhile, Sri Lanka will purchase 2 to 3 million doses on the Oxford-AstraZeneca vaccine from Serum Institute of India in the next few days.
Tune in to the Coronavirus Essential podcast for more.
Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.
